Shandong Pharmaceutical GlassLtd (600529) Stock Overview
Manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
600529 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shandong Pharmaceutical Glass Co.Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.12 |
| 52 Week High | CN¥32.00 |
| 52 Week Low | CN¥21.13 |
| Beta | 0.38 |
| 1 Month Change | 3.03% |
| 3 Month Change | -5.23% |
| 1 Year Change | -12.71% |
| 3 Year Change | -20.72% |
| 5 Year Change | -58.62% |
| Change since IPO | 631.62% |
Recent News & Updates
Recent updates
There Is A Reason Shandong Pharmaceutical Glass Co.Ltd's (SHSE:600529) Price Is Undemanding
Dec 13
Returns On Capital At Shandong Pharmaceutical GlassLtd (SHSE:600529) Have Hit The Brakes
Aug 25Calculating The Fair Value Of Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)
May 31The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing
May 13Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 26Shareholder Returns
| 600529 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -1.8% | 1.7% | 3.3% |
| 1Y | -12.7% | -2.0% | 20.7% |
Return vs Industry: 600529 underperformed the CN Medical Equipment industry which returned -2% over the past year.
Return vs Market: 600529 underperformed the CN Market which returned 20.7% over the past year.
Price Volatility
| 600529 volatility | |
|---|---|
| 600529 Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 9.8% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600529 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600529's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 7,116 | Jun Zhang | www.pharmglass.com |
Shandong Pharmaceutical Glass Co Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection vial comprising type I/II/III.
Shandong Pharmaceutical Glass Co.Ltd Fundamentals Summary
| 600529 fundamental statistics | |
|---|---|
| Market cap | CN¥14.68b |
| Earnings (TTM) | CN¥945.83m |
| Revenue (TTM) | CN¥5.10b |
Is 600529 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600529 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.10b |
| Cost of Revenue | CN¥3.55b |
| Gross Profit | CN¥1.55b |
| Other Expenses | CN¥607.77m |
| Earnings | CN¥945.83m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 30.46% |
| Net Profit Margin | 18.54% |
| Debt/Equity Ratio | 0% |
How did 600529 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/29 07:41 |
| End of Day Share Price | 2025/06/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Pharmaceutical Glass Co.Ltd is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Zhang | BOCI Research Ltd. |
| Liang Long | Chasing Securities |
| Maoda Yang | China International Capital Corporation Limited |